Human Laboratory Study of Apremilast for Alcohol Use Disorder

Abroad (travel likely)RecruitingPHASE2

Conditions

Alcohol Use Disorder · Alcohol Misuse

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of California, Los Angeles, California, United States

    Contact: Study coordinator (Jessica Jenkins, MS) · jenkinsj@ucla.edu · 310-206-6756
    Contact: Principal Investigator (Lara Ray, PhD)
  • University of Colorado, Aurora, Colorado, United States

    Contact: Study coordinator (Kristen Raymond) · kristen.raymond@cuanschutz.edu
    Contact: Principal Investigator (Joseph Schacht, PhD)
  • University of Virginia, Charlottesville, Virginia, United States

    Contact: Study coordinator (Eva Jenkins-Mendoza, BS) · emj9c@hscmail.mcc.virginia.edu · 434-243-0562
    Contact: Study coordinator (Tracie Kostelac) · 434.243.0563
    Contact: Principal Investigator (Nassima Ait-Daoud Tiouririne, MD)
Study leads
  • Daniel Falk, PhD

    Principal Investigator

    National Institute on Alcohol Abuse and Alcoholism (NIAAA)